Six children, aged 6 to 10, walked out of a clinic standing taller than they'd been in years—some for the first time without assistance. The breakthrough came from a device no heavier than a small backpack: a lightweight robotic knee robot that is rewriting what's possible for children living with spinal muscular atrophy.
Spinal muscular atrophy is a rare neuromuscular disorder that weakens the nerves controlling muscle movement, often leaving children unable to perform basic tasks like standing or walking without help. While physical therapy—particularly isokinetic resistance training, which uses speed-controlled exercises to rebuild strength—has long offered a path forward, the equipment required has remained locked away in specialist institutions, too bulky and complicated for children to use outside laboratory settings. That barrier is now crumbling.
Yanggang Feng and colleagues designed a wearable knee robot weighing just 0.96 kilograms that makes isokinetic training portable and accessible. In a clinical trial published in Nature, they tested the device with six children who had SMA type II, the intermediate form of the condition. None of these children could stand from a seated position without assistance when the trial began.
The results arrived quickly. After six weeks of training—five times per week with the robotic device—all six children achieved the same milestone: they could stand unassisted. Their quadriceps muscle volume increased by 19%, and their overall knee function improved measurably. The team then continued with six more weeks of lighter-intensity training three times weekly, before transitioning the children back to conventional physical therapy alone.
What happened next is what makes this work truly significant. When researchers followed up 30 days later, the children had maintained their gains in function. They hadn't regressed. This persistence—the fact that temporary exposure to the robotic device produced lasting recovery—suggests that the gains are not merely cosmetic improvements but reflect genuine neuromuscular adaptation.
"Temporary exposure to the wearable isokinetic training robot device can facilitate prolonged neuromuscular recovery," the researchers concluded. For families navigating SMA, those words carry enormous weight. A child who regains the ability to stand independently gains not just physical capacity but dignity, independence, and a transformed relationship with their own body.
The work does come with realistic caveats. The trial involved only six children—a small cohort necessary partly because SMA is rare and historically has carried poor outcomes. Larger trials will be needed to fully understand how broadly and effectively the device works across different patients and settings. The researchers also note that modifications targeting different muscle groups could expand the device's potential beyond knee function alone.
Still, the path forward is clear. A palm-sized robotic device has opened a door that seemed sealed shut. For children with SMA type II, and potentially for others with neuromuscular conditions, the future may look different from what it did even a year ago—not just more hopeful in spirit, but more capable in practice.